Tuesday, June 11, 2013

Health Guides

Craig Stoltz

Craig Stoltz, Health Guide

(Profile)
Health Journalist

Research on Prozac as an MS Treatment is Still Preliminary

The recent report that Prozac may slow the development of brain lesions is the sort of news that maybe shouldn't be reported at all. It's so preliminary that it's of value almost exclusively to researchers. It appears to invite people with MS to consider taking Prozac to slow the disease. It shouldn't.   Three things you need to... Read moreChevron
Joan Ohayon, CRNP

Joan Ohayon, CRNP, Health Guide

(Profile)

Managing Multiple Sclerosis by Therapy

Managing multiple sclerosis (MS) by therapy may essentially be divided into three areas of focus: treating the acute relapse, managing symptoms and targeting disease pathology. The gold standard for treating a MS exacerbation has remained unchanged over recent years. Generally, most clinicians recommend three to five days of intravenous... Read moreChevron